R Squared’s Zimmer Biomet ZBH Stock Holding History

R Squared’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-600	Closed	-$63.4K	–	1537
2024 Q4	$63.4K	Buy	+600	New	+$64.4K	0.06%	411

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

R Squared's ZBH Position: Q1 2025 in Review

R Squared sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 600 shares — an estimated $63.4K sold.

R Squared first reported a position in ZBH in Q4 2024 and held it in 1 quarter. The position peaked at $63.4K in Q4 2024. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

R Squared reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
R Squared sold 600 Zimmer Biomet shares in Q1 2025, an estimated $63.4K.
R Squared first reported a position in Zimmer Biomet in Q4 2024 and held it in 1 quarter.
R Squared's Zimmer Biomet position peaked at $63.4K in Q4 2024.
1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.